Hangzhou Tigermed Consulting Co., Ltd (HNGZY) Investment Research Dashboard
About Hangzhou Tigermed Consulting Co., Ltd (HNGZY) stock analysis
Get live HNGZY stock price $4.00, comprehensive Hangzhou Tigermed Consulting Co., Ltd stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time HNGZY stock data and investment insights.
Loading chart data...
Hangzhou Tigermed Consulting Co., Ltd (HNGZY) Overview
Hangzhou Tigermed Consulting Co., Ltd (HNGZY) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, HNGZY trades at $4.00 with a market capitalization of 6.16B . Over the past 52 weeks, HNGZY has traded between $4.00 and $4.45 , with the current price positioned at approximately 0% of this range . The stock cur...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 6.16B
- Current price: $4.00
- 52-week range: $4.00 - $4.45
- P/E ratio: 32.82
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People's Republic of China and internationally. The company offers clinical trial operation services, such as clinical phar...
Company Information
- CEO
- Xiao Chun Cao
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 11130
Contact Information
- Website
- https://www.tigermed.net
- Address
- No. 508, Lujiatan Street
- Country
- CN
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 32.8)
✓ Lower volatility stock (Beta: 0.41) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Hangzhou Tigermed Consulting Co., Ltd shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Hangzhou Tigermed Consulting Co., Ltd
- ⚠Investors should consider how Hangzhou Tigermed Consulting Co., Ltd fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 32.8) requires strong growth to justify
Market Cap
6.16B
P/E Ratio (TTM)
32.82
Beta
0.41
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare HNGZY with peer companies:
- Price
- $22.25+0.00% (1D)
- Market cap
- 5.12B
- Price
- $5.49+0.00% (1D)
- Market cap
- 4.05B
- Price
- $4.10+0.00% (1D)
- Market cap
- 5.37B
- Price
- $46.90+0.00% (1D)
- Market cap
- 5.34B
- Price
- $98.00+0.00% (1D)
- Market cap
- 5.58B
- Price
- $115.00+0.00% (1D)
- Market cap
- 5.73B
- Price
- $1.71+0.00% (1D)
- Market cap
- 15.11B
- Price
- $185.93+64.35% (1D)
- Market cap
- 15.38B
- Price
- $18.99+0.00% (1D)
- Market cap
- 3.44B
- Price
- $7.30+0.00% (1D)
- Market cap
- 879.03M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.8 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.4% | 29.2 | 46/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 35/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.